News

During Heart Month, we talk about why prevention is key and exciting new research that reveals there may be a new way to help slow aging and lengthen our lifespan.

During Heart Month, we are talking about the risks of undiagnosed heart failure and treatment options for those with heart failure.

TCTMD talked to Dr. Vittal Hejjaji about a large registry study that looked at when patients quit smoking following an atherosclerotic cardiovascular disease event.

During Heart Month, we are talking about atrial fibrillation, the recent changes in guidelines, and how Saint Luke’s is leading the way in innovative treatments for those who have a-fib.

FOX4 talked to Ted Perez and his heart transplant surgeon, Dr. Russ Davis, about the lifelong Chiefs fan's incredible story.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

The groundbreaking STEP-HFpEF study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named one of the top advances by the American Heart Association.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

The heart transplant team at Saint Luke’s Mid America Heart Institute recently performed its 1,000th transplant, reaching a prestigious milestone less than 25 hospitals in the nation have managed to accomplish.

A man from Columbia, Missouri, got a new heart and a second chance at life, marking the 1,000th heart transplant at Saint Luke's Mid America Heart Institute.